Trials / Unknown
UnknownNCT06174259
Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients
Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients: a Prospective Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Breast cancer is the most common cancer type among women in Egypt and world. Preclinical studies show fasting reduces growth factors and modulates nutrient sensing systems, protecting normal cells against chemotherapy. However, cancer cells are not protected due to Differential Stress Resistance (DSR), making them more vulnerable to chemotherapeutics. This study aims to evaluate intermittent fasting impact on neoadjuvant chemotherapy in breast cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | intermittent fasting | 16/8 intermittent fasting (limiting foods and calorie-containing beverages to a set window of 8 hours per day) |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2024-06-01
- Completion
- 2025-06-01
- First posted
- 2023-12-18
- Last updated
- 2024-02-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06174259. Inclusion in this directory is not an endorsement.